These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9754251)

  • 41. In vitro anti-Vibrio cholerae activity of essential oil from Lepechinia caulescens.
    Acevedo JG; López JL; Cortés AM; Bores AM; Cortés GM; Castro IP
    Fitoterapia; 2005 Jan; 76(1):104-7. PubMed ID: 15664471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe diarrhea caused by cholera toxin-producing vibrio cholerae serogroup O75 infections acquired in the southeastern United States.
    Tobin-D'Angelo M; Smith AR; Bulens SN; Thomas S; Hodel M; Izumiya H; Arakawa E; Morita M; Watanabe H; Marin C; Parsons MB; Greene K; Cooper K; Haydel D; Bopp C; Yu P; Mintz E
    Clin Infect Dis; 2008 Oct; 47(8):1035-40. PubMed ID: 18781876
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tetracycline in the treatment of cholera caused by Vibrio cholerae O1 resistant to the drug in vitro.
    Khan AM; von Gierke U; Hossain MS; Fuchs GJ
    J Health Popul Nutr; 2003 Mar; 21(1):76-8. PubMed ID: 12751678
    [No Abstract]   [Full Text] [Related]  

  • 44. Cholera--the new epidemic?
    Keddy KH; Koornhof HJ
    S Afr Med J; 1998 Oct; 88(10):1313-4. PubMed ID: 9807185
    [No Abstract]   [Full Text] [Related]  

  • 45. Plants used in Guatemala for the treatment of gastrointestinal disorders. IV. Vibriocidal activity of five American plants used to treat infections.
    Cáceres A; Torres MF; Ortiz S; Cano F; Jauregui E
    J Ethnopharmacol; 1993 May; 39(1):73-5. PubMed ID: 8331964
    [No Abstract]   [Full Text] [Related]  

  • 46. Outbreak of cholera caused by Vibrio cholerae 01 intermediately resistant to norfloxacin at Malda, West Bengal.
    Bhattacharya MK; Ghosh S; Mukhopadhyay AK; Deb A; Bhattacharya SK
    J Indian Med Assoc; 2000 Jul; 98(7):389-90. PubMed ID: 11143861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of Vibrio cholerae virulence genes in response to environmental signals.
    Peterson KM
    Curr Issues Intest Microbiol; 2002 Sep; 3(2):29-38. PubMed ID: 12400636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence of bacterial enteropathogens among hospitalized diarrhea patients from Orissa, India.
    Samal SK; Khuntia HK; Nanda PK; Satapathy CS; Nayak SR; Sarangi AK; Sahoo N; Pattnaik SK; Chhotray GP; Pal BB
    Jpn J Infect Dis; 2008 Sep; 61(5):350-5. PubMed ID: 18806340
    [TBL] [Abstract][Full Text] [Related]  

  • 49. National guideline for the management of Chlamydia trachomatis genital tract infection. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
    Sex Transm Infect; 1999 Aug; 75 Suppl 1():S4-8. PubMed ID: 10616372
    [No Abstract]   [Full Text] [Related]  

  • 50. Class 1 integrons and SXT elements conferring multidrug resistance in Vibrio cholerae O1 strains associated with a recent large cholera outbreak in Orissa, Eastern India.
    Jain M; Kumar P; Goel AK; Kamboj DV; Singh L
    Int J Antimicrob Agents; 2008 Nov; 32(5):459-60. PubMed ID: 18706789
    [No Abstract]   [Full Text] [Related]  

  • 51. Cholera epidemic in and around Loni a rural area in western Maharashtra.
    Gujrathi UP; Sivarajan K; Kulkarni SG
    Indian J Pathol Microbiol; 2000 Jan; 43(1):101-2. PubMed ID: 12583433
    [No Abstract]   [Full Text] [Related]  

  • 52. Characterization of a clinical Vibrio cholerae O139 isolate from Mexico.
    Parveen S; Farrah SR; Gonzalez-Bonilla C; Zamudio AV; Tamplin ML
    Can J Microbiol; 2003 Jan; 49(1):65-70. PubMed ID: 12674350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial treatment of adults with cholera due to Vibrio cholerae 0139 (synonym Bengal).
    Khan WA; Dhar U; Begum M; Salam MA; Bardhan PK; Mahalanabis D
    Drugs; 1995; 49 Suppl 2():460-2. PubMed ID: 8549400
    [No Abstract]   [Full Text] [Related]  

  • 54. Acute acalculous cholecystitis due to Vibrio cholerae.
    Gomez NA; Gutierrez J; Leon CJ
    Lancet; 1994 May; 343(8906):1156-7. PubMed ID: 7910242
    [No Abstract]   [Full Text] [Related]  

  • 55. Transition of drug susceptibilities of Vibrio cholerae O1 in Lao People's Democratic Republic.
    Phantouamath B; Sithivong N; Sisavath L; Munnalath K; Khampheng C; Insisiengmay S; Higa N; Kakinohana S; Iwanaga M
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):95-9. PubMed ID: 11485103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Azithromycin in the treatment of cholera in children.
    Bhattacharya MK; Dutta D; Ramamurthy T; Sarkar D; Singharoy A; Bhattacharya SK
    Acta Paediatr; 2003 Jun; 92(6):676-8. PubMed ID: 12856976
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survey of antibiogram tests in cholera patients in the 2005 epidemic in Hamadan, Islamic Republic of Iran.
    Keramat F; Hashemi SH; Mamani M; Ranjbar M; Erfan H
    East Mediterr Health J; 2008; 14(4):768-75. PubMed ID: 19166158
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vibrio cholerae O139 Bengal: a descriptive study.
    Hossain MS; Salam MA; Rabbani GH; Biswas R; Mahalanabis D
    J Health Popul Nutr; 2000 Jun; 18(1):27-32. PubMed ID: 11014767
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutaneous manifestations of non-01 Vibrio cholerae septicemia with gastroenteritis and meningitis.
    Chan HL; Ho HC; Kuo TT
    J Am Acad Dermatol; 1994 Apr; 30(4):626-8. PubMed ID: 8157789
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current pathogenetic, clinical and therapeutic aspects of cholera].
    Terragna A
    Minerva Med; 1971 Nov; 62(90):4437-46. PubMed ID: 5162745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.